2022-05-26 10:19:45 RVVTF Revive Therapeutics
05/26/22 05/2610:19 05/26/2210:19 | Revive Therapeutics provides update on Phase 3 trial for bucillamine in COVID-19Revive Therapeutics is pleased to provide an update on the Company's U.S. Food & Drug Administration Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine, an oral drug with anti-inflammatory and antiviral properties, in patients with mild to moderate COVID-19. The Company has received positive comments from the FDA in regards to the Company's request to determine and agree on the Study's potential new primary efficacy endpoints, including the rate of sustained clinical resolution of symptoms of COVID-19, which addresses the shift in COVID-19 clinical outcome observed over the course of the pandemic, and, therefore, to have more meaningful study endpoints for the FDA to consider for potential Emergency Use Authorization. The FDA has agreed that the Company may unblind the pre-dose-selection data for the first 210 patients of the Study to further support the new primary endpoint. Before unblinding the pre-dose selection data for the first 210 patients, the Company will submit a Data Access Plan to the FDA in early June 2022 with the aim to unblind the pre-dose selection data and submit the amended Study protocol with the new primary efficacy endpoints to the FDA. In addition, the Data Safety and Monitoring Board are scheduled to meet thereafter to evaluate the interim clinical and safety data and may make a recommendation on continuing the Study or advise on halting the Study early due to positive efficacy based on other clinical outcomes such as the rate of sustained clinical resolution of symptoms of COVID-19. The DSMB supported the continuation of the Study in its last meeting as there were no serious adverse events or safety concerns reported. |
---|
Recommendations
|
Rogers Sugar price target raised to C$6.50 from C$6 at Scotiabank »
12:10 08/12/22 08/1212:10 08/12/2212:10
RSGUF
Rogers Sugar
Scotiabank analyst George… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Onex price target lowered to C$105 from C$118 at Scotiabank »
12:10 08/12/22 08/1212:10 08/12/2212:10
ONEXF
Onex
Scotiabank analyst Phil… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Kits Eyecare price target lowered to C$3.50 from C$5 at Scotiabank »
12:09 08/12/22 08/1212:09 08/12/2212:09
KTYCF
Kits Eyecare
Scotiabank analyst George… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
KP Tissue price target lowered to C$11 from C$11.50 at Scotiabank »
12:09 08/12/22 08/1212:09 08/12/2212:09
KPTSF
KP Tissue
Scotiabank analyst Benoit… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Dialogue Health price target lowered to C$8 from C$8.50 at Scotiabank »
12:08 08/12/22 08/1212:08 08/12/2212:08
DLHTF
Dialogue Health
Scotiabank analyst Adam… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Chemtrade Logistics price target raised to C$10.50 from C$10.25 at Scotiabank »
12:07 08/12/22 08/1212:07 08/12/2212:07
CGIFF
Chemtrade Logistics
Scotiabank analyst Ben… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Badger Infrastructure price target lowered to C$38 from C$40 at Scotiabank »
12:05 08/12/22 08/1212:05 08/12/2212:05
BADFF
Badger Infrastructure
Scotiabank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Antofagasta price target lowered to 1,250 GBp from 1,300 GBp at Scotiabank »
12:05 08/12/22 08/1212:05 08/12/2212:05
ANFGF
Antofagasta
Scotiabank analyst Orest… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Illumina price target lowered to $240 from $350 at Morgan Stanley »
12:04 08/12/22 08/1212:04 08/12/2212:04
ILMN
Illumina
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
AG Growth International price target raised to C$55 from C$52 at Scotiabank »
12:04 08/12/22 08/1212:04 08/12/2212:04
AGGZF
AG Growth International
Scotiabank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Humacyte price target lowered to $3.50 from $4.00 at Piper Sandler »
12:02 08/12/22 08/1212:02 08/12/2212:02
HUMA
Humacyte
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
SmartRent falls -32.7% »
12:00 08/12/22 08/1212:00 08/12/2212:00
SMRT
SmartRent
SmartRent is down -32.7%,… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
| Olo is down -33.8%, or… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
| CS Disco is down -54.0%,… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
| ESS Inc. is up 17.5%, or… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Xponential Fitness rises 21.1% »
12:00 08/12/22 08/1212:00 08/12/2212:00
XPOF
Xponential Fitness
Xponential Fitness is up… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
| Invitae is up 29.0%, or… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Savaria price target raised to C$20 from C$19 at TD Securities »
11:59 08/12/22 08/1211:59 08/12/2211:59
SISXF
Savaria
TD Securities analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Peyto Exploration price target lowered to C$18.50 from C$19 at TD Securities »
11:59 08/12/22 08/1211:59 08/12/2211:59
PEYUF
Peyto Exploration
TD Securities analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Killam Apartment REIT price target raised to C$22 from C$21 at TD Securities »
11:59 08/12/22 08/1211:59 08/12/2211:59
KMMPF
Killam Apartment REIT
TD Securities analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Goeasy price target raised to C$200 from C$195 at TD Securities »
11:58 08/12/22 08/1211:58 08/12/2211:58
EHMEF
Goeasy
TD Securities analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Canadian Apartment Properties price target raised to C$60 at TD Securities »
11:58 08/12/22 08/1211:58 08/12/2211:58
CDPYF
Canadian Apartment Properties
TD Securities analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Vermilion Energy price target raised to C$45 from C$40 at TD Securities »
11:57 08/12/22 08/1211:57 08/12/2211:57
VET
Vermilion Energy
TD Securities analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
OverActive Media price target lowered to C$1.50 from C$2 at TD Securities »
11:57 08/12/22 08/1211:57 08/12/2211:57
OAMCF
OverActive Media
TD Securities analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Next Hydrogen Solutions price target raised to C$5.50 from C$4 at TD Securities »
11:56 08/12/22 08/1211:56 08/12/2211:56
NXHSF
Next Hydrogen Solutions
TD Securities analyst… Story temporarily locked. ShowHide Related Items >><<
|